Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort

American Journal of Medicine

Volumn 100, Issue 2, 1996, Pages 193-196

  Matteson, Eric L ^a   Gold, Kenneth N ^a   Bloch, Daniel A ^b   Hunder, Gene G ^a  

^a MAYO CLINIC   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GIANT CELL ARTERITIS; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0030025473     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)89458-2     Document Type: Article

References (21)

1. Lie JT. The classification and diagnosis of vasculitis in large and medium-sized blood vessels. Pathol Annu. 1987;22:125-162.
2. Hauser WA, Ferguson RH, Holley KE, Kurland LT. Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc. 1971;46:597-602.
3. Machado EBV, Michet CJ, Ballard DJ, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 1988;31:745-749.
4. Graham E. Survival in temporal arteritis. Trans Opthalmol Soc UK. 1980; 100(pt 1):108-110.
5. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88:162-167.
6. Andersson R, Malmvall B-E, Bengtsson B-A. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acad Med Scand. 1986;220:361-364.
7. Nordborg E, Bengtsson B-A. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ. 1989;229:549-550.
8. Jonasson F, Cullen JF, Elton RA. Temporal arteritis: a 14-year epidemiological, clinical and prognostic study. Scott Med J. 1979;24:111-117.
9. Godeau P, Aubert L, Guillevin L, et al. Aspect clinique, evolution et pronostic de la maladie de Horton. Ann Med Interne (Paris). 1982;133:393-400.
10. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: a prospective investigation, 1982-1985. Arthritis Rheum. 1987;30:294-299.
11. Gouet D, Marechaud R, Le Berre D, et al. Pronostic de l'arterite temporale traitee: etude retrospective de 87 observations. Presse Med. 1986; 15:603-606.
12. Barrier J, Tournemaine N, Maulaz D, et al. Evolution, traitement et pronostic de la maladie de Horton. Ann Med Interne (Paris). 1983;134:428-435.
13. Bisgard C, Sloth H, Keiding N, Juel K. Excess mortality in grant cell arteritis. J Intern Med. 1991;230:119-123.
14. Graham E, Holland A, Avery A, Russell RWR. Prognosis in giant cell arteritis. BMJ. 1981;282:269-271.
15. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum. 1990;33: 1065-1144.
16. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.
17. United States Department of Health and Human Services. Life Tables of the United States (1950-1990). Hyattsville, Maryland: National Center for Health Statistics; 1992.
18. Health Division of Vital Statistics and Disease Registration Section. Statistics Canada: Life Tables, Canada and Provinces (1950-1990). Ottawa: Health Division of Vital Statistics and Disease Registration Section; 1992.
19. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford: Blackwell Scientific Publications; 1987.
20. Ostberg G. Morphological changes in large arteries in polymyalgia rheumatica. Acta Med Scand. 1972;533 (suppl):135-159.
21. Evans JM, Bowles CA, Bjornsson J, et al. Thoracic aortic aneurysm and rupture in giant cell arteritis. Arthritis Rheum. 1994;37:1539-1547.